U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07723079) titled 'Single-case Intervention Study for Visual Screening Assessment for Proof of Concept and Prediction of Clinical Response to Brexiprazole as Adjunctive Treatment in Adults With Major Depressive Disorder.' on April 06.
Brief Summary: Major Depressive Disorder (MDD) is the most prevalent mental disorder in the world, with high rates of recurrence and dysfunction. A significant portion of patients do not respond adequately to conventional treatments, highlighting the need to search for biomarkers capable of predicting clinical response.
A relevant marker in depression is attentional bias, which is characterized by the preferential proce...